TITLE

Are Vaccines Safe after Guillain-Barré and Chronic Inflammatory Demyelinating Neuropathy

AUTHOR(S)
Rubin, Michael
PUB. DATE
May 2010
SOURCE
Travel Medicine Advisor;May2010, Vol. 20 Issue 5, p25
SOURCE TYPE
Periodical
DOC. TYPE
Opinion
ABSTRACT
In this article the author reflects on a study whether it is safe to vaccinate patients with a past history of Guillain-Barré syndrome (GBS) or chronic inflammatory demyelinating polyneuropathy (CIPD). The author mentions that vaccinations appear to be rarely associated to the recurrence of GBS. Moreover, he notes that the formulations of rabies vaccine, derived from chick embryo cells, are similarly not linked with a greater than expected rate of GBS.
ACCESSION #
49548230

 

Related Articles

  • Case Study: Ascending Guillain-Barrà Syndrome in the Intensive Care Unit Nursing Considerations. Walsh, Simone // Nursing Monograph;Jan2006, p25 

    Guillain-Barrè Syndrome (GBS), a rapid and degenerative disease process affecting a large number of our population poses significant nursing concerns, due to its debilitating affects. This disorder is characterised by demyelination of nervous tissue, resulting in impaired saltatory conduction...

  • Meningococcal vaccine groups A C Y W-135 conjugate.  // Reactions Weekly;5/6/2006, Issue 1100, p16 

    Presents the study "Update: Guillain-Barre Syndrome Among Recipients of Menactra(Rm) Meningococcal Conjugate Vaccine-United States," which appeared in the April 2006 issue of "Morbidity and Mortality Weekly Report." Medical condition of the patients with Guillain-Barré syndrome; Results of...

  • Menactra: information updated on Guillain Barre syndrome.  // Reactions Weekly;10/28/2006, Issue 1125, p2 

    The article discusses cases of meningococcal vaccine groups A C Y W-135 or Menactra-related Guillain Barre Syndrome (GBS), reported to the Vaccine Adverse Event Reporting System. Individuals developed CBS within six weeks of receiving Menactra. A possible increase of about 1.25 GBS cases is...

  • Guillain-Barré Syndrome Among Recipients of Menactra Meningococcal Conjugate Vaccine -- United States, June--July 2005.  // MMWR: Morbidity & Mortality Weekly Report;10/14/2005, Vol. 54 Issue 40, p1023 

    Cites several case reports on Guillain-Barré syndrome among recipients of a quadrivalent meningococcal conjugate vaccine (MCV4) in the U.S. Components of MCV4; Number of reported cases of Guillaine-Barré syndrome in persons who have received MCV4 vaccination as of October 4, 2005;...

  • Application of Information Retrieval Approaches to Case Classification in the Vaccine Adverse Event Reporting System. Botsis, Taxiarchis; Woo, Emily; Ball, Robert // Drug Safety;2013, Vol. 36 Issue 7, p573 

    Background: Automating the classification of adverse event reports is an important step to improve the efficiency of vaccine safety surveillance. Previously we showed it was possible to classify reports using features extracted from the text of the reports. Objective: The aim of this study was...

  • Update on Guillain-Barré Syndrome and Menactra Meningococcal Conjugate Vaccine. Scully, Mary-Louise // Infectious Disease Alert;Mar2007, Vol. 26 Issue 6, p67 

    This report summarizes the 9 additional reports of Guillain-Barré Syndrome to the Vaccine Adverse Event Reporting System (VAERS) during March through September 2006. There have now been a total of 17 cases. Although the available data suggest a small increased risk for Guillain-Barré...

  • U.S. Probes GBS Linked to Sanofi Meningitis Vaccine.  // Clinical Infectious Diseases;12/1/2005, Vol. 41 Issue 11, preceding p1 

    This article reports that the U.S. government has announced that the U.S. officials are investigating if a Sanofi-Aventis meningitis vaccine may have caused five cases of Guillain-Barré syndrome (GBS). The patients, all 17 or 18 years old have developed GBS after receiving Sanofi's Menactra...

  • Editor's comment.  // Clinical Infectious Diseases;12/1/2005, Vol. 41 Issue 11, preceding p1 

    This article focuses on the outbreak of Guillain-Barré syndrome (GBS) in the U.S. At present, the report of 5 cases of GBS after more than 2.5 million doses of vaccine have been distributed is not outside of what might be expected by chance alone. Concerns are that the current reporting...

  • 'I sure would love my old life and body back' Milne, Mary // Nutrition Action Health Letter;May2002, Vol. 29 Issue 4, p4 

    Presents an article on suffering from a Guillain-Barr é Syndrome.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics